Affirm Journal of Gene Therapy

Affirm Journal of Gene Therapy is an international and peer-reviewed journal with an intercontinental advisory board. The journal documents the professional’s interest in any areas that connect to gene therapy. The focus of the journal is on theories and practice in clinical applications of gene therapy, cancer gene therapy, methods for gene delivery, gene therapy for severe combined immunodeficiencies, ethical and social problems of gene therapy, and novel genetic targets. The editorial board of the Affirm Journal of Gene Therapy invites authors to submit original papers, case studies and review papers to the journal. At Affirm Journal of Gene Therapy, we expect the authors to abide Principles of Transparency and Best Practice in Scholarly Publishing suggested by The Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and Scopus.

Scope and Focus

Animal Models
Cancer Gene Therapy
Clinical Applications of Gene Therapy
Clinical Applications of Novel Therapeutic Techniques
Ethical and Social Problems of Gene Therapy
Gene Therapy for Cystic Fibrosis
Gene Therapy for Severe Combined Immunodeficiencies
Gene Therapy of Familial Hypercholesterolemia
Gene Transfection Using Particle Bombardment
Gene Transfer and Gene Expression Analysis
Human Clinical Applications
Liposomes in Gene Therapy
Methods for Gene Delivery
Novel Genetic Targets
Receptor Mediated Gene Transfer
Vector Development

Editor in chief

Dr. Loghman

Abstracting and Indexing

Google Scholar